oxycodone vs fentanyl in IV-PCA after LSH

A comparison of fentanyl and oxycodone for patient controlled analgesia after laparoscopic supracervical hysterectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001928

Enrollment

130

Registered

2016-05-24

Start date

2015-04-11

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The patient received fentanyl 100 mcg with ketorolac 30 mg IV after operation and then continued 100 ml-mixture of 700 µg of fentanyl, 150 mg of ketorolac, and 0.6 mg of ramosetron with a norma

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients between the ages of 18-65 who had been classified as American Society of Anesthesiologists (ASA) physical status 1 and 2, were scheduled for laparoscopic supracervical hysterectomy at our hospital, and had requested IV-PCA after the operation.

Exclusion criteria

Exclusion criteria: Patients with a history of bleeding tendencies, hepatitis and renal failure, those with habitual sedative or other drug use, those with mental diseases, and those not suitable for IV-PCA, were excluded from the study.

Design outcomes

Primary

Measure	Time frame
infused PCA dose, postoperative pain using numerical rating scale,	—

Secondary

Measure	Time frame
side effects, patients satisfaction, rescue analgesics	—

Countries

Korea, Republic of

Contacts

Public ContactNan Seol KIM

Soon Chun Hyang University Hospital Cheonan

nskim1977@naver.com+82-41-570-2722

Outcome results